3.7.0.1 html 173 248 1 false 62 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://nuvectramedical.com/20170630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unuadited) Sheet http://nuvectramedical.com/20170630/role/statement-condensed-consolidated-balance-sheets-current-period-unuadited Condensed Consolidated Balance Sheets (Current Period Unuadited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unuadited) (Parentheticals) Sheet http://nuvectramedical.com/20170630/role/statement-condensed-consolidated-balance-sheets-current-period-unuadited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unuadited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://nuvectramedical.com/20170630/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://nuvectramedical.com/20170630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statement of Stockholders' Equity (Unaudited) Sheet http://nuvectramedical.com/20170630/role/statement-condensed-consolidated-statement-of-stockholders-equity-unaudited Condensed Consolidated Statement of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Summary of Significant Accounting Policies Sheet http://nuvectramedical.com/20170630/role/statement-note-1-summary-of-significant-accounting-policies Note 1 - Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Intangible Assets Sheet http://nuvectramedical.com/20170630/role/statement-note-2-intangible-assets Note 2 - Intangible Assets Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Accrued Liabilities Sheet http://nuvectramedical.com/20170630/role/statement-note-3-accrued-liabilities Note 3 - Accrued Liabilities Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Employee Benefit Plans Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans Note 4 - Employee Benefit Plans Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Other Operating Expenses Sheet http://nuvectramedical.com/20170630/role/statement-note-5-other-operating-expenses Note 5 - Other Operating Expenses Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Debt Sheet http://nuvectramedical.com/20170630/role/statement-note-6-debt Note 6 - Debt Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Income Taxes Sheet http://nuvectramedical.com/20170630/role/statement-note-7-income-taxes Note 7 - Income Taxes Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Commitments and Contingencies Sheet http://nuvectramedical.com/20170630/role/statement-note-8-commitments-and-contingencies Note 8 - Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Earnings (Loss) Per Share ("EPS") Sheet http://nuvectramedical.com/20170630/role/statement-note-9-earnings-loss-per-share-eps Note 9 - Earnings (Loss) Per Share ("EPS") Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Fair Value Measurements Sheet http://nuvectramedical.com/20170630/role/statement-note-10-fair-value-measurements Note 10 - Fair Value Measurements Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information Note 11 - Business Segment, Geographic and Concentration Risk Information Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Related Party Transactions Sheet http://nuvectramedical.com/20170630/role/statement-note-12-related-party-transactions Note 12 - Related Party Transactions Notes 18 false false R19.htm 018 - Document - Note 13 - Recently Issued Accounting Standards Sheet http://nuvectramedical.com/20170630/role/statement-note-13-recently-issued-accounting-standards Note 13 - Recently Issued Accounting Standards Uncategorized 19 false false R20.htm 019 - Disclosure - Significant Accounting Policies (Policies) Sheet http://nuvectramedical.com/20170630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 2 - Intangible Assets (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-2-intangible-assets-tables Note 2 - Intangible Assets (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 3 - Accrued Liabilities (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-3-accrued-liabilities-tables Note 3 - Accrued Liabilities (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 4 - Employee Benefit Plans (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-tables Note 4 - Employee Benefit Plans (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 6 - Debt (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-6-debt-tables Note 6 - Debt (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 9 - Earnings (Loss) Per Share ("EPS") (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-9-earnings-loss-per-share-eps-tables Note 9 - Earnings (Loss) Per Share ("EPS") (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 10 - Fair Value Measurements (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-10-fair-value-measurements-tables Note 10 - Fair Value Measurements (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information (Tables) Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information-tables Note 11 - Business Segment, Geographic and Concentration Risk Information (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-1-summary-of-significant-accounting-policies-details-textual Note 1 - Summary of Significant Accounting Policies (Details Textual) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 2 - Intangible Assets - Amortizing Intangible Assets (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-2-intangible-assets-amortizing-intangible-assets-details Note 2 - Intangible Assets - Amortizing Intangible Assets (Details) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 2 - Intangible Assets - Aggregate Intangible Asset Amortization Expense (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-2-intangible-assets-aggregate-intangible-asset-amortization-expense-details Note 2 - Intangible Assets - Aggregate Intangible Asset Amortization Expense (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 2 - Intangible Assets - Future Intangible Asset Amortization Expense (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-2-intangible-assets-future-intangible-asset-amortization-expense-details Note 2 - Intangible Assets - Future Intangible Asset Amortization Expense (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 3 - Accrued Liabilities - Accrued Liabilities (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-3-accrued-liabilities-accrued-liabilities-details Note 3 - Accrued Liabilities - Accrued Liabilities (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 4 - Employee Benefit Plans (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-details-textual Note 4 - Employee Benefit Plans (Details Textual) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 4 - Employee Benefit Plans - Allocated Stock-based Compensation Expense (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-allocated-stockbased-compensation-expense-details Note 4 - Employee Benefit Plans - Allocated Stock-based Compensation Expense (Details) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 4 - Employee Benefit Plans - Weighted Average Fair Value Assumption Used to Values Options Granted (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-weighted-average-fair-value-assumption-used-to-values-options-granted-details Note 4 - Employee Benefit Plans - Weighted Average Fair Value Assumption Used to Values Options Granted (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 4 - Employee Benefit Plans - Summary of Stock Option Activity (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-summary-of-stock-option-activity-details Note 4 - Employee Benefit Plans - Summary of Stock Option Activity (Details) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 4 - Employee Benefit Plans - Summary Restricted Stock Unit Activity (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-4-employee-benefit-plans-summary-restricted-stock-unit-activity-details Note 4 - Employee Benefit Plans - Summary Restricted Stock Unit Activity (Details) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 5 - Other Operating Expenses (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-5-other-operating-expenses-details-textual Note 5 - Other Operating Expenses (Details Textual) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 6 - Debt (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-6-debt-details-textual Note 6 - Debt (Details Textual) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 6 - Debt - Long-term Debt (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-6-debt-longterm-debt-details Note 6 - Debt - Long-term Debt (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 6 - Debt - Deferred Financing Fees (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-6-debt-deferred-financing-fees-details Note 6 - Debt - Deferred Financing Fees (Details) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 7 - Income Taxes (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-7-income-taxes-details-textual Note 7 - Income Taxes (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 8 - Commitments and Contingencies (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-8-commitments-and-contingencies-details-textual Note 8 - Commitments and Contingencies (Details Textual) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 9 - Earnings (Loss) Per Share ("EPS") (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-9-earnings-loss-per-share-eps-details-textual Note 9 - Earnings (Loss) Per Share ("EPS") (Details Textual) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 9 - Earnings (Loss) Per Share ("EPS") - Basic and Diluted Earnings Per Share (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-9-earnings-loss-per-share-eps-basic-and-diluted-earnings-per-share-details Note 9 - Earnings (Loss) Per Share ("EPS") - Basic and Diluted Earnings Per Share (Details) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 10 - Fair Value Measurements (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-10-fair-value-measurements-details-textual Note 10 - Fair Value Measurements (Details Textual) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 10 - Fair Value Measurements - Marketable Securities Measured at Fair Value (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-10-fair-value-measurements-marketable-securities-measured-at-fair-value-details Note 10 - Fair Value Measurements - Marketable Securities Measured at Fair Value (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 10 - Fair Value Measurements - Fair Value Assumptions of Warrants (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-10-fair-value-measurements-fair-value-assumptions-of-warrants-details Note 10 - Fair Value Measurements - Fair Value Assumptions of Warrants (Details) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information-details-textual Note 11 - Business Segment, Geographic and Concentration Risk Information (Details Textual) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information - Product Line Sales (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information-product-line-sales-details Note 11 - Business Segment, Geographic and Concentration Risk Information - Product Line Sales (Details) Uncategorized 50 false false R51.htm 050 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information - Business Segments Information (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information-business-segments-information-details Note 11 - Business Segment, Geographic and Concentration Risk Information - Business Segments Information (Details) Uncategorized 51 false false R52.htm 051 - Disclosure - Note 11 - Business Segment, Geographic and Concentration Risk Information - Sales by Geographic Area (Details) Sheet http://nuvectramedical.com/20170630/role/statement-note-11-business-segment-geographic-and-concentration-risk-information-sales-by-geographic-area-details Note 11 - Business Segment, Geographic and Concentration Risk Information - Sales by Geographic Area (Details) Uncategorized 52 false false R53.htm 052 - Disclosure - Note 12 - Related Party Transactions (Details Textual) Sheet http://nuvectramedical.com/20170630/role/statement-note-12-related-party-transactions-details-textual Note 12 - Related Party Transactions (Details Textual) Uncategorized 53 false false All Reports Book All Reports nvtr-20170630.xml nvtr-20170630.xsd nvtr-20170630_cal.xml nvtr-20170630_def.xml nvtr-20170630_lab.xml nvtr-20170630_pre.xml true true